Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Sleep Length and Interruptions Linked to Prostate Cancer Risk Over 23 Years

Updated

Abstract

Among 32,141 men, 6% reported never feeling rested upon waking, which is associated with an increased risk of lethal prostate cancer.

  • 2% of men reported sleeping 5 hours or less per night in 1987.
  • No consistent association was found between habitual sleep duration or changes in sleep duration and the risk of advanced or lethal prostate cancer.
  • Sleep disruptions, such as waking during the night or difficulty falling asleep, did not show a relationship with prostate cancer risk.
  • Men who never felt rested upon waking had a relative risk of 3.05 for developing lethal prostate cancer compared to those who always felt rested.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Conflicts of interest: Dr. Czeisler has received research support from Philips Respironics, and has an ownership interest in Vanda Pharmaceuticals. Dr. Czeisler has received consulting fees or served as a paid member of scientific advisory boards for: Bose Corporation, Merck and Company, Quest Diagnostics, Samsung Electronics, Teva Pharmaceuticals, and Vanda Pharmaceuticals. Dr. Czeisler has also served as an expert witness on various legal matters, including Purdue Pharma L.P and Philips Respironics.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free